How to better monitor and manage health? This was the subject of discussion at Impact ‘21, featuring Jarosław Kieszek from the e-Health Centre, Tomasz Skrzypczak, Managing Director at Janssen Poland, and Piotr Węcławik from the Ministry of Health. The digitalization of the healthcare system is a challenge that is absolutely essential in today's world. Poland already has e-prescriptions and e-referrals available, but the health sector requires further changes. Katarzyna Mokrzycka from 300Research asked her guests whether and when we will be able to book doctor's appointments online. "Already at the beginning of next year, a pilot program for central e-registration with selected specialists will commence. Registration for vaccinations was an excellent training ground where we learned a great deal. And this was true for everyone, not just the developers of these solutions, but primarily for medical professionals who were forced to create calendars within the IT system. I believe they passed this test excellently. We will build the central e-registration solution based on this experience," informed Jarosław Kieszek, e-Health Centre. How Can the Private Sector Support Public Health? It is difficult to imagine modern public healthcare without leveraging the technologies of the private sector. Private companies can play a significant role in improving healthcare services. "We develop drugs that are tailored to specific patients with specific conditions. For example, we are developing CAR-T technology, and clinical trials concerning the use of this therapy in multiple myeloma are being conducted, among other places, in Poland. However, personalized therapies are expensive, so it is important to develop risk-sharing mechanisms based on therapeutic effect. This brings us to the issue of access to data that would enable actual payment for results. This means that by observing the effects of therapy, it would be possible to determine whether the government or the pharmaceutical company should bear the cost. Such a solution would broaden patient access to innovative medical technologies," stated Tomasz Skrzypczak, Managing Director of Janssen Polska. Editor Mokrzycka asked Piotr Węcławik, from the Innovation Department at the Ministry of Health, whether the ministry is considering expanding its offerings to include such innovative solutions. Piotr Węcławik replied: "Of course. However, we must pay attention to the sensitivity of the data that would be made available." Digital Diagnostics Katarzyna Mokrzycka inquired about Janssen Pharmaceutical Companies' experience in digital diagnostics. "Janssen is the pharmaceutical part of Johnson & Johnson, responsible for innovative drug technologies, and my role is to increase the accessibility of these therapies for patients in Poland. However, J&J is also a leading inventor of medical equipment that has revolutionized the tools available to clinicians worldwide. Experience from various projects globally shows that the most crucial element is the ease of use of a given device, as well as its integration with a particular system. In short, as J&J, we support patients and doctors at every stage of battling illness," informed Tomasz Skrzypczak, Managing Director of Janssen Polska.